Pristyn Care, a prominent leader in secondary surgeries in India, has unveiled the Pristyn Care Innovation Lab (PCIL), an initiative aimed at driving advancements in artificial intelligence (AI) within the healthcare sector.
In a press statement on Friday, the company informed that this newly established incubator will serve as a testing ground for early-stage AI startups, offering them the opportunity to pilot and validate their products in real-world healthcare settings.
From the 47 startups that have applied, a select few will be chosen to collaborate with Pristyn Care. These selected startups will have access to a unique platform that includes real-world testing environments, product validation, ecosystem access, growth opportunities, infrastructure support, and sales assistance.
The Indian healthcare sector is projected to reach USD 650 billion by 2025, with the AI market expected to grow to USD 1.6 billion, according to a report by Nasscom and Kantar. As AI becomes increasingly vital in transforming healthcare delivery, Pristyn Care's Innovation Lab aims to foster innovation and accelerate the development of groundbreaking AI technologies.
The lab will provide comprehensive support to selected startups, including access to anonymised patient data, operational workflows, and pilot programs in specific departments like patient interaction and insurance analysis. Additionally, startups will receive expert feedback from Pristyn Care’s medical experts, operational staff, and technology teams, along with mentorship from top leadership in healthcare, operations, and technology.
"We are excited to partner with AI startups to drive a revolution in Indian healthcare," said Harsimarbir Singh, Co-founder of Pristyn Care. “The adoption of AI is not just a trend but a crucial necessity for transforming the healthcare landscape in India. Through the Innovation Lab, we aim to foster innovation, accelerate the development of groundbreaking AI solutions, and address the pressing challenges facing Indian healthcare.
